Structure Therapeutics Inc. Stock Prediction and Forecast [GPCR]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 16 Aug 2025, 03:11 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Structure Therapeutics Inc. Stock Prediction and Forecast [GPCR]](https://i.ytimg.com/vi/KlCoa0YVXU4/hqdefault.jpg)
AI-generated source summary
The analysis suggests a general sell signal due to the long-term average being above the short-term average. Downward corrections may find support at $18.08 and $18.60. A drop below these levels may trigger sell signals. However, a buy signal was issued from a pivot bottom on August 7, 2025, with the stock rising 24.20% since. Further rise is indicated until a new top pivot is established. MACD shows a buy signal and the volume is rising.The 3 months trend suggests a negative 26.21% change. 12 months projects change negative 55.47% a future price between $2.27 and $9.05. Resistance at $21.79 and support at $17.80. P/E Ratio: -5.96.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.